FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Denton Pharma Metformin Hydrochloride Extended-Release Recall

Metformin Hydrochloride Extended-Release Tablets USP 750 mg, 30 Tablets bottle, Rx Only…

Denton Pharma, Inc. · North Blenheim, NY

Risk level
Class II
Reported by FDA
Nov 11, 2020
Recall ID
D-0056-2021
Check your lot numberHow we source this data

Summary

Denton Pharma recalled Metformin Hydrochloride Extended-Release starting Oct 8, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0056-2021 on Nov 11, 2020. Reason: CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer). Status: Ongoing.

Why it was recalled

CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)

Product description

Metformin Hydrochloride Extended-Release Tablets USP 750 mg, 30 Tablets bottle, Rx Only, Time-Cap Labs, Inc., Repackaged By: Northwind Pharmaceuticals North Blenheim NY 12131 NDC 70934-334-30

Lot numbers, UPCs & expiration codes

N107411901, N107411903, N107411904, N107411905, N107411906, exp 11/30/2020; N107411907, N107412001, exp 4/30/2021; N107412002, N107412004, exp 11/30/2021; N107412003, exp 7/31/2021

Where it was sold

Indiana - Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0056-2021
Classification
Class II
Status
Ongoing
Recall initiated
Oct 8, 2020
FDA report date
Nov 11, 2020
Quantity
N/A
Recall type
Voluntary: Firm initiated
Recalling firm
Denton Pharma, Inc.

Original FDA data

Every field from FDA enforcement report D-0056-2021, exactly as published.

Show all FDA fields
City
North Blenheim
State
NY
Status
Ongoing
Country
United States
Event ID
86593
Address
119 Creamery Rd
Code information
N107411901, N107411903, N107411904, N107411905, N107411906, exp 11/30/2020; N107411907, N107412001, exp 4/30/2021; N107412002, N107412004, exp 11/30/2021; N107412003, exp 7/31/2021
Postal code
12131-1613
Report date
Nov 11, 2020
Product type
Drugs
Recall number
D-0056-2021
Classification
Class II
Recalling firm
Denton Pharma, Inc.
Reason for recall
CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level (per manufacturer)
Voluntary / mandated
Voluntary: Firm initiated
Product description
Metformin Hydrochloride Extended-Release Tablets USP 750 mg, 30 Tablets bottle, Rx Only, Time-Cap Labs, Inc., Repackaged By: Northwind Pharmaceuticals North Blenheim NY 12131 NDC 70934-334-30
Distribution pattern
Indiana - Nationwide.
Recall initiation date
Oct 8, 2020
Initial firm notification
Letter
Center classification date
Nov 2, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0056-2021, published Nov 11, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls